Table 1

Expression of MLH1 in surgical specimens with or without neoadjuvant chemotherapy in ESCC patients

A. MLH1 expressiona
HighLowTotal
Neoadjuvant chemotherapyTreated67 (62.6%)40 (37.4%)107 (100%)
Untreated37 (86.0%)6 (14.0%)43 (100%)
B. P53 expressionb
PositiveNegativeTotal
Neoadjuvant chemotherapyTreated75 (70.1%)32 (29.9%)107 (100%)
Untreated26 (60.5%)17 (39.5%)43 (100%)
  • a Fisher’s exact test; P = 0.0057.

  • b Fisher’s exact test; P = 0.3357.